TUESDAY, Dec. 7, 2021 (HealthDay News) — Genetic testing can help guide management and treatment of unexplained epilepsy in children, new research suggests. “A genetic diagnosis impacted medical management for nearly three out of four children in our study,” said study author Dr. Isabel Haviland. She’s a postdoctoral research fellowContinue Reading

MONDAY, Dec. 6, 2021 (HealthDay News) — New research offers fresh proof that the COVID-19 pandemic delayed cancer diagnoses in the United States, increasing patients’ risk for poor outcomes. For the study, researchers analyzed data from more than 9 million patients at over 1,200 Veterans Affairs (VA) medical facilities. ProceduresContinue Reading

THURSDAY, Dec.2, 2021 (HealthDay News) — For those who think vaping is safer than smoking, think again. A new study warns that vaping triggers the same gene regulation changes that smoking does, so it may raise the risk of cancer and other serious diseases. “Our study, for the first time,Continue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — A U.S. Food and Drug Administration advisory panel on Tuesday voted narrowly to recommend emergency use of Merck’s new antiviral pill to help prevent severe COVID-19 in high-risk patients. By a 13-10 count, the panelists recommended molnupiravir for use by older COVID-19 patientsContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — Coffee lovers know a steaming cup of java can quickly deliver energy and mental clarity every morning, but new research suggests it may also guard against Alzheimer’s disease in the long run. “Worldwide, a high proportion of adults drink coffee every day, makingContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — Older blood thinners, especially when taken in combination with daily low-dose aspirin, are associated with a higher risk of brain bleeds and death after hospital discharge in patients treated for head injury, new research shows. The risk fell when patients were taking oneContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — U.S. cancer clinical trial participants have become more diverse in makeup, but certain groups remain underrepresented, a new study finds. It’s important to have a wide range of participants in clinical trials, to find out if treatments are safe and effective for peopleContinue Reading